Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Autolus reported Q1 2025 net product sales of $9.0 million. The Company has 39 centers fully activated in the U.S. as of May 7, 2025. Patient access to AUCATZYL continues to increase, with coverage ...

In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...

Kangpu Biopharmaceuticals, Ltd. announced today that the Center for Drug Evaluation (CDE) of China's National Medical ...

This review provides an overview of the pathophysiology, genetic basis, clinical manifestations, and available management of these channelopathies (Figure 1). A comprehensive understanding of these ...

The Department of Clinical Sciences faculty are committed to the provision of high-quality, evidence-based patient care and educating the next generation of health care professionals. Our ultimate ...

Spanning four continents and enrolling hundreds of people, a new clinical trial will test the effectiveness of two anti-inflammatory medicines as potential treatments for long COVID, scientists ...

Company outlined potential for value creation driven by obe-cel across multiple B cell driven malignancies and autoimmune diseases, incl ...

And they saw that, although, at first, deaths from lupus were related to organ manifestations or infections ... I know that we've had some randomized clinical trials in lupus patients, one ...

A rash accompanied by swollen lymph nodes usually stems from a viral infection, such as measles, chickenpox, or mononucleosis. A rash is an inflammatory response that causes changes to your skin ...